Literature DB >> 28362418

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking.

Ashley M Fox-Loe1, Brandon J Henderson2, Christopher I Richards3.   

Abstract

Understanding membrane protein trafficking, assembly, and expression requires an approach that differentiates between those residing in intracellular organelles and those localized on the plasma membrane. Traditional fluorescence-based measurements lack the capability to distinguish membrane proteins residing in different organelles. Cutting edge methodologies transcend traditional methods by coupling pH-sensitive fluorophores with total internal reflection fluorescence microscopy (TIRFM). TIRF illumination excites the sample up to approximately 150 nm from the glass-sample interface, thus decreasing background, increasing the signal to noise ratio, and enhancing resolution. The excitation volume in TIRFM encompasses the plasma membrane and nearby organelles such as the peripheral ER. Superecliptic pHluorin (SEP) is a pH sensitive version of GFP. Genetically encoding SEP into the extracellular domain of a membrane protein of interest positions the fluorophore on the luminal side of the ER and in the extracellular region of the cell. SEP is fluorescent when the pH is greater than 6, but remains in an off state at lower pH values. Therefore, receptors tagged with SEP fluoresce when residing in the endoplasmic reticulum (ER) or upon insertion in the plasma membrane (PM) but not when confined to a trafficking vesicle or other organelles such as the Golgi. The extracellular pH can be adjusted to dictate the fluorescence of receptors on the plasma membrane. The difference in fluorescence between TIRF images at neutral and acidic extracellular pH for the same cell corresponds to a relative number of receptors on the plasma membrane. This allows a simultaneous measurement of intracellular and plasma membrane resident receptors. Single vesicle insertion events can also be measured when the extracellular pH is neutral, corresponding to a low pH trafficking vesicle fusing with the plasma membrane and transitioning into a fluorescent state. This versatile technique can be exploited to study localization, expression, and trafficking of membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28362418      PMCID: PMC5409030          DOI: 10.3791/55466

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Plasma membrane insertion of the AMPA receptor GluA2 subunit is regulated by NSF binding and Q/R editing of the ion pore.

Authors:  Yoichi Araki; Da-Ting Lin; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors.

Authors:  Guillermo A Yudowski; Manojkumar A Puthenveedu; Dmitri Leonoudakis; Sandip Panicker; Kurt S Thorn; Eric C Beattie; Mark von Zastrow
Journal:  J Neurosci       Date:  2007-10-10       Impact factor: 6.167

3.  Trafficking of alpha4* nicotinic receptors revealed by superecliptic phluorin: effects of a beta4 amyotrophic lateral sclerosis-associated mutation and chronic exposure to nicotine.

Authors:  Christopher I Richards; Rahul Srinivasan; Cheng Xiao; Elisha D W Mackey; Julie M Miwa; Henry A Lester
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

4.  Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.

Authors:  J R Pauly; M J Marks; S F Robinson; J L van de Kamp; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

5.  Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor.

Authors:  Francesca Mazzo; Francesco Pistillo; Giovanni Grazioso; Francesco Clementi; Nica Borgese; Cecilia Gotti; Sara Francesca Colombo
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

6.  Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Authors:  Brandon J Henderson; Teagan R Wall; Beverley M Henley; Charlene H Kim; Weston A Nichols; Ruin Moaddel; Cheng Xiao; Henry A Lester
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

7.  Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.

Authors:  C Banerjee; J R Nyengaard; A Wevers; R A de Vos; E N Jansen Steur; J Lindstrom; K Pilz; S Nowacki; W Bloch; H Schröder
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

Review 8.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

9.  Dynamic visualization of membrane-inserted fraction of pHluorin-tagged channels using repetitive acidification technique.

Authors:  Serguei S Khiroug; Evgeny Pryazhnikov; Sarah K Coleman; Andreas Jeromin; Kari Keinänen; Leonard Khiroug
Journal:  BMC Neurosci       Date:  2009-11-30       Impact factor: 3.288

10.  Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors.

Authors:  Brandon J Henderson; Rahul Srinivasan; Weston A Nichols; Crystal N Dilworth; Diana F Gutierrez; Elisha D W Mackey; Sheri McKinney; Ryan M Drenan; Christopher I Richards; Henry A Lester
Journal:  J Gen Physiol       Date:  2014-01       Impact factor: 4.086

View more
  1 in total

1.  ER-GCaMP6f: An Endoplasmic Reticulum-Targeted Genetic Probe to Measure Calcium Activity in Astrocytic Processes.

Authors:  Surya P Aryal; Mengfan Xia; Ebubechi Adindu; Caroline Davis; Pavel I Ortinski; Christopher I Richards
Journal:  Anal Chem       Date:  2022-01-21       Impact factor: 8.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.